A phase I/II study of capecitabine given on a week on/week off schedule combined with bevacizumab and oxaliplatin for patients with untreated advanced colorectal cancer
Rajesh Sehgal, Barry C. Lembersky, Kiran K. Rajasenan, Theodore L. Crandall, Edward Balaban, Richard A. Pinkerton, Patrick Kane, Amy Schmotzer, Herbert Zeh, Douglas M. Potter, Ramesh K. Ramanathan
Dive into the research topics of 'A phase I/II study of capecitabine given on a week on/week off schedule combined with bevacizumab and oxaliplatin for patients with untreated advanced colorectal cancer'. Together they form a unique fingerprint.